5月2日周五，德康医疗（DexCom）股价盘中大涨7.30%，引发市场广泛关注。这一显著涨幅主要受到公司第一季度财报超预期和多家分析师维持看好评级的推动。
据悉，德康医疗周四晚间公布的第一季度财报显示，公司实现销售额10.4亿美元，高于分析师预期的10.2亿美元。尽管每股收益32美分略低于33美分的预期，但公司重申了全年46亿美元的销售指引，展现出对未来业绩的信心。这一财报表现超出市场预期，成为推动股价上涨的主要因素之一。
此外，多家券商对德康医疗的前景保持乐观态度，进一步提振了投资者信心。摩根大通分析师罗比·马库斯表示，公司采取了"保守的做法"，预计"在今年余下的时间里会有更好的表现"。Canaccord Genuity将德康医疗的目标价从103美元上调至106美元，Leerink Partners也将目标价从95美元上调至101美元。这些积极的分析师评级和目标价上调，为股价提供了有力支撑。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.